About

Track Chair
John Nicols
Organicols
CEO
In light of anticipated surges in the global requisition for chemicals and materials, there arises a concomitant potential for economic expansion. However, this uptick is shadowed by environmental concerns, given the energy profligacy and associated harmful emissions of conventional production modalities. Notably, nascent synthetic biology methodologies present promising avenues for redressing these environmental challenges. As the clarion call for cleaner and more efficacious technologies amplifies among consumers and governing bodies, industrial and international collaborative efforts become imperative to facilitate the large-scale adoption of these sustainable innovations.
Speakers
Agenda
Agenda
Monday
May 05
Tuesday
May 06
Wednesday
May 07
Pioneers in Pharma Manufacturing: Using Synthetic Biology to Build New, Innovative Complex Chemical Structures
-
As demand for genetic medicines grows, traditional manufacturing methods are reaching their limits. Leaders in pharma and synbio explore what’s driving innovation in cell and gene therapy (CGT), RNA/DNA therapeutics, and other complex manufacturing spaces, with insights from plasmid DNA production, vaccine manufacturing, and the broader chemicals sector.
Thursday
May 08
The View (of Synbio) From Global Chemical Industry Leaders
-
Huge opportunities to help the multi-trillion dollar global chemical industry to transform its global footprint more sustainably. But so far, adoption has been limited. This panel will delve deeper into the opportunities and realities for synthetic biology to accelerate its impact into the crucial market.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495